CalciMedica (CALC) vs Lexaria Bioscience (LEXX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CalciMedica is the larger company by market cap ($8.7 million vs $8.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CALC | LEXX |
|---|---|---|
| Share price | $1.26 | $4.03 |
| Market cap | $8.69M | $8.49M |
| 1-day change | +7.69% | -10.24% |
| YTD return | -96.18% | — |
| 1-year return | -92.34% | — |
| EPS (TTM) | $-4.41 | $-5.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $705.92K |
| Revenue growth (YoY) | — | +52.05% |
| Net income (latest FY) | $-29.56M | $-11.90M |
| Gross margin | — | 99.61% |
| Operating margin | — | -1683.01% |
| Net margin | — | -1686.00% |
| 52-week high | $36.00 | $21.60 |
| 52-week low | $1.00 | $2.43 |
| Distance from 52-week high | -96.50% | -81.34% |
| Analyst consensus | none | none |
| Avg. price target upside | +3868.25% | +1947.15% |
| Average volume | 80.15K | 70.52K |
| Shares outstanding | 6.90M | 2.11M |
| Employees | 15 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CalciMedica
CALC stock →CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.
Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees
About Lexaria Bioscience
LEXX stock →Lexaria Bioscience Corp. operates as a biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
CALC vs LEXX FAQ
Which is bigger, CalciMedica or Lexaria Bioscience?
CalciMedica (CALC) is larger, with a market capitalization of $8.69M compared with $8.49M for Lexaria Bioscience (LEXX).
Are CalciMedica and Lexaria Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.